What we do
We accelerate promising life science for rare diseases and global health challenges, through funding, partnerships, and scientific and commercialisation support.

Funding
Find details of open funding calls, including eligibility criteria.

Scientific support
Drug discovery, antibody humanization and discovery and diagnostics development through our labs.

Commercialisation and IP protection
Technology transfer services and expert advice to protect and bring your research to market.

Investment in early ventures
Seed and series A investments, plus significant scientific support and follow-on investment.

Interested in partnering with us?
We often provide support through multiple capabilities. Get in touch to discover how we can support you.

Policy and public affairs
We talk to decision-makers across the political spectrum who influence the way research and innovation happen in the UK.
By sharing our expertise and collaborating with others, we hope to shape a better system for translating promising life science into life-changing health impact for people with rare diseases.

Contact us
In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email info@lifearc.org.
Please see our Privacy Policy in relation to the personal data you submit to us through this page.
Latest news
-
LifeArc joins the REMEDi4ALL Consortium, a pioneering global platform shaping the future of drug repurposing
-
£1million partnership aims to develop new treatments for congenital muscular dystrophy
-
Tribune Therapeutics raises EUR 37 million for next-generation anti-fibrotic therapies